ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,520 | -18.9% | 3,582 | -9.0% | 0.06% | -16.4% |
| Q2 2023 | $112,884 | -12.3% | 3,936 | -26.7% | 0.07% | -5.6% |
| Q1 2023 | $128,647 | +2.1% | 5,367 | -27.8% | 0.07% | +7.6% |
| Q4 2022 | $126,030 | +5.0% | 7,431 | -8.2% | 0.07% | +37.5% |
| Q3 2022 | $120,000 | -5.5% | 8,092 | +0.7% | 0.05% | +2.1% |
| Q2 2022 | $127,000 | +4.1% | 8,039 | +77.4% | 0.05% | -14.5% |
| Q1 2022 | $122,000 | -31.5% | 4,532 | -5.6% | 0.06% | -17.9% |
| Q4 2021 | $178,000 | -37.1% | 4,803 | -18.8% | 0.07% | -46.4% |
| Q3 2021 | $283,000 | +34.1% | 5,913 | -5.1% | 0.12% | +43.7% |
| Q2 2021 | $211,000 | +83.5% | 6,229 | +123.7% | 0.09% | +77.6% |
| Q1 2021 | $115,000 | -3.4% | 2,785 | +1.5% | 0.05% | 0.0% |
| Q4 2020 | $119,000 | – | 2,743 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |